Scott Holmstrom | Vice President
Elanco Animal Health

Scott Holmstrom, Vice President, Elanco Animal Health

 
Scott Holmstrom received his doctorate in analytical chemistry from Miami University in 2000 and joined Elanco Animal Health the same year. Dr. Holmstrom has provided chemistry, drug disposition expertise, and significant leadership contributions toward the development and commercialization of drug products for Elanco, including global approvals for Comfortis and Trifexis. Additionally, from 2011 – 2013, he served to integrate the Jannsen Animal Health research and development efforts with those of Elanco.
 
From 2013-2016, Dr. Holmstrom led global regulatory affairs for Elanco. In this role, he was responsible for shaping the regulatory landscape to enable outcomes for Elanco and their customers, and to ensure that Elanco deliverables are completed in accordance with appropriate regulations and commitments to global regulatory authorities.
 
In 2016, Scott led Elanco’s efforts for development and execution on late stage external innovation strategies.  During this time, Galliprant was in-licensed following the development of specific strategies and execution plans to partner with external companies to commercialize products for Elanco.
 
Currently, Dr. Holmstrom currently serves as Vice President, Global Product Development, leading Elanco’s global product development efforts, for food and companion and food producing animals, including  pharmaceuticals, biopharmaceutics, and vaccines. In this role, he provides the strategic direction for the global development of products through external and internal coordination, governance, and resourcing.
 

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071